Nuclear fragmentation cross sections for therapy beams
48No. 787 in all physics · No. 37 in Medical and Radiation Physics
Measure and model partial charge-changing and isotopic production cross sections for projectiles of Z from 2 to 10 at 100 to 450 MeV per nucleon on hydrogen, carbon, nitrogen, oxygen and calcium targets, to about 5 percent, including fragment angular and energy distributions. An answer is a cross-section set that lets Monte Carlo transport reproduce measured depth-dose tails to within 1 percent of peak dose.
What would settle it
Thin-target fragmentation experiments covering the therapeutic energy range, benchmarked against measured depth-dose and lateral profiles.
Status in the literature
Unverified note: it names recent work and was partly written without a live literature search; it awaits a check by an editor.
Dedicated campaigns since about 2020 have filled gaps, yet model spread in the fragment tail remained several percent in 2025.
No solutions, ideas or subproblems yet.
See also
- Related Which ion species is optimal for therapy?
- Related Diffusion coefficient and halo size from secondary-to-primary ratios
Details, signature and history
- Kind
- Well-posed question
- Answer
- Value
- Posed
- 1990
- Topic review
- Paganetti, Relative biological effectiveness (RBE) values for proton beam therapy: variations as a function of biological endpoint, dose, and linear energy transfer, Physics in Medicine and Biology, 2014. Link
- Record
- Revision 1 · imported from the seed collection · compiled by AI, not yet reviewed by an editor
Proof
- Fingerprint
- 1d9f1a7d04e8…
- Public log
- Entry 1,689, in checkpoint 2,123
- In the log by
- Block 969,698, 2026-10-03
This text was in the PubPhys log by that date. The date says nothing about when the problem was first posed.
Comments (0)
Comments are not records: they are not signed, stamped or logged. How comments work
No comments yet.
Sign in to comment.